IDiyas

For the Inventor, By the Inventor

Funabashi, Japan

Ryozo Sakoda

USPTO Granted Patents = 25

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 212(Granted Patents)


Location History:

  • Kashiwa, JP (1986 - 1992)
  • Funabashi, JP (1980 - 1996)

Company Filing History:

goldMedal25 out of 1,235 
 
Nissan Chemical Industries Limited
 patents
silverMedal2 out of 191 
 
Sagami Chemical Research Center
 patents
where one patent can have more than one assignee

Years Active: 1980-1996

Loading Chart...
25 patents (USPTO):Explore Patents
1. 5508403 - Phosphorus pyridine compound (1996-04-16),
2. 5319089 - Process for the optical resolution of pyranobenzoxadiazole compounds (1994-06-07),
3. 5318968 - 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones (1994-06-07),
4. 5314883 - 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones (1994-05-24),
5. 5304550 - Drug effect-enhancing agent for antitumor drug (1994-04-19),
6. 5272271 - Pyranobenzoxadiazole derivatives (1993-12-21),
7. 5202323 - 5-arylmethylamino-6-oxy-substituted 3(2H)-pyridazinones (1993-04-13),
8. 5177237 - Hydrazine derivatives useful as intermediates in the synthesis of (1993-01-05),
9. 5130303 - Drug effect-enhancing agent for antitumor drug (1992-07-14),
10. 5100702 - Thin platinum film-forming composition (1992-03-31),
11. 5098900 - 3(2H)pyridazinone, process for its preparation and anti-allergic agent (1992-03-24),
12. 5097037 - Process for the optical resolution of pyranobenzoxadiazole compounds (1992-03-17),
13. 4978665 - 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it (1990-12-18),
14. 4900752 - Pyranobenzoxadiazole derivatives (1990-02-13),
15. 4892947 - 3(2H)Pyridazinone, process for its preparation and anti-allergic agent (1990-01-09),

Title: Ryozo Sakoda: A Pioneer in Pharmaceutical Innovations

Introduction: Ryozo Sakoda, located in Funabashi, Japan, is an accomplished inventor with a remarkable portfolio of 25 patents. His innovative contributions, particularly in the fields of pharmaceuticals and chemical compounds, have significantly advanced drug development and treatment efficacy.

Latest Patents: Among Sakoda's latest patents is a groundbreaking phosphorus pyridine compound that serves as an agent for enhancing the drug effects of an antitumor medication. This compound, described by a specific formula, represents a novel approach in cancer treatment. Additionally, he developed a process for the optical resolution of pyranobenzoxadiazole compounds, which involves reacting the compound with an optically active carboxylic acid and subsequently separating the diastereomeric salt. These inventions demonstrate his dedication to improving pharmaceutical technologies and drug therapies.

Career Highlights: Throughout his career, Ryozo Sakoda has made significant strides in the field of chemistry and pharmaceuticals. He has worked with renowned companies such as Nissan Chemical Industries Limited and Sagami Chemical Research Center. His expertise in developing advanced chemical processes has set him apart as a leading innovator in his industry.

Collaborations: Sakoda has collaborated with esteemed colleagues, including Kiyotomo Seto and Keizo Tanikawa. Their joint efforts have contributed to the effectiveness and efficiency of the innovative processes and compounds they developed together.

Conclusion: Ryozo Sakoda's extensive work and patent portfolio reflect his significant influence in pharmaceutical innovations. Through his dedication and collaborative spirit, he continues to propel advancements in drug development, ensuring better outcomes for patients and the medical community at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…